Sagaliam (NASDAQ:SAGA), which previously announced it had signed a non-binding letter of intent (LOI) for the purchase of Biogenysis, Inc. and Virogentics Inc., operating subsidiaries of Enzolytics Inc. (OTC Pink: ENZC), announced this afternoon that it has now executed a definitive business combination agreement. ...READ MORE
Biotech firms tend to come on to SPACs’ radar when they still have some clinical work to complete to get to an approved medicine or device, but Avertix is ahead of that particular curve. ...READ MORE
Sustainable materials are starting to take a bite out of the share of single-use plastics in circulation, but replacing the full $600 billion plastics market is going to take more innovation and much more capital. ...READ MORE
Renewable energy sources have long been pressed on the fact that most can only supply power for certain portions of the day. But, what if you could combine multiple renewable technologies into a refinery that had round-the-clock output? ...READ MORE
A press release yesterday announced that ROTH MKM managed to scoop up Gil Ottensoser and Anthony Mazzurco, both of which are SPAC veterans and both having previously worked at BTIG. ...READ MORE
As companies find new ways of automating business processes with AI, a new AI-driven approach to auto insurance is heading West from India with the help of a SPAC deal.
This week, we speak Rohan Malhotra, CEO and co-founder of Roadzen and Steven Carlson from the sponsor of Vahanna Tech Edge Acquisition I Corp. ...READ MORE
This week, we get an update from Brandon Mintz, CEO of Bitcoin Depot (Nasdaq: BTM), which recently closed its SPAC combination with GSR II Meteora Acquisition Corp. in June.
Brandon shares what advice he has for other companies considering a SPAC merger in the current market and discusses how Bitcoin Depot is hitting the ground running with its acquisition pipeline now that it has public capital at its disposal. ...READ MORE
Well, this is a new one. Have you ever watched a TV show like Grey’s Anatomy and thought, “Yeah, I could do surgery.” The answer is no, no you can’t. ...READ MORE
By John Umbach and Andrew Fiscella, Marsh’s SPAC leaders
Additional contribution from Michael Gil and Paul Figliozzi, Marsh’s Turnaround & Restructuring Practice leaders
For more information on SPAC risk and Marsh’s SPAC risk specialists, visit Marsh.com ...READ MORE
SPAC structures can provide unique opportunities to bring together many pieces to a new puzzle, which is very much the case with this week’s deal.
This week, we speak with John Schaible, Chairman and CEO of Quantum Fintech Acquisition Corporation (NYSE: QFTA), and Craig Ridenhour, Chief Business Development Officer at AtlasClear. ...READ MORE
The London Stock Exchange has seen several of its companies decamp for Wall Street and SPACs have become a new avenue for those companies to skip across the pond.
This week, we speak with Hervé Tessler, CEO of Noventiq (LSE:NVNQ) and Jerry Letter, CFO and COO of Corner Growth Acquisition Corp. ...READ MORE